Widefield, Swept-Source Optical Coherence Tomography Angiography Metrics as Predictors of Anti-VEGF Treatment in Retinal Vein Occlusions
BACKGROUND AND OBJECTIVE: Our objective was to assess baseline widefield swept-source optical coherence tomography angiography (WF SSOCTA) microvascular metrics as predictors for the number of anti-vascular endothelial growth factor (VEGF) injections and visual acuity (VA) at 12-months follow-up in...
Publié dans: | Ophthalmic surgery, lasers & imaging retina. - 2013. - 55(2024), 7 vom: 01. Juli, Seite 374-382 |
---|---|
Auteur principal: | |
Autres auteurs: | , , , , , , , , , , , , , |
Format: | Article en ligne |
Langue: | English |
Publié: |
2024
|
Accès à la collection: | Ophthalmic surgery, lasers & imaging retina |
Sujets: | Journal Article Angiogenesis Inhibitors Vascular Endothelial Growth Factor A Ranibizumab ZL1R02VT79 |
Résumé: | BACKGROUND AND OBJECTIVE: Our objective was to assess baseline widefield swept-source optical coherence tomography angiography (WF SSOCTA) microvascular metrics as predictors for the number of anti-vascular endothelial growth factor (VEGF) injections and visual acuity (VA) at 12-months follow-up in patients with retinal vein occlusion (RVO) PATIENTS AND METHODS: This was a prospective study including 49 RVO eyes from 49 patients who had not received an anti-VEGF injection for at least 3 months prior to imaging. Microvascular metrics from 6×6-mm and 12×12-mm angiograms were assessed using linear regression models, adjusting for age RESULTS: Reductions in the vessel density (VD) and vessel skeletonized density (VSD) vascular metrics were associated both with a higher number of anti-VEGF injections at all follow-up time points and reduced VA 12 months after imaging in all RVO eyes CONCLUSIONS: WF SS-OCTA VD and VSD micro-vascular metrics at baseline can prognosticate VA and number of anti-VEGF injections required at 3, 6, and 12 months in RVO eyes. [Ophthalmic Surg Lasers Imaging Retina 2024;55:374-382.] |
---|---|
Description: | Date Completed 16.07.2024 Date Revised 14.08.2024 published: Print-Electronic Citation Status MEDLINE |
ISSN: | 2325-8179 |
DOI: | 10.3928/23258160-20240208-02 |